Breast Cancer
Evaluation may include mammography, breast ultrasound, MRI, biopsy, receptor testing, genetic assessment and planning for surgery, systemic therapy and radiotherapy.
Comprehensive cancer diagnosis and treatment through multidisciplinary tumor boards, precision oncology, advanced surgery, systemic therapies, radiation oncology, nuclear medicine and supportive care.
Our platform helps international patients access experienced oncology teams, advanced diagnostic technologies and personalized treatment planning for adult and pediatric cancers.
Medical reports, pathology, radiology, laboratory results and previous treatments are reviewed before treatment recommendations are prepared.
Complex cases may be discussed by medical oncologists, surgeons, radiation oncologists, radiologists, pathologists, nuclear medicine physicians and other specialists.
Molecular and genetic tests may help identify tumor-specific biomarkers and guide targeted treatment, immunotherapy and individualized treatment strategies.
Our team supports medical review, quotations, appointment scheduling, travel coordination, interpreter services and follow-up planning.
Multidisciplinary evaluation is available for a broad range of solid tumors, blood cancers and complex oncological conditions.
Evaluation may include mammography, breast ultrasound, MRI, biopsy, receptor testing, genetic assessment and planning for surgery, systemic therapy and radiotherapy.
Diagnosis and staging may involve CT, PET/CT, bronchoscopy, biopsy and molecular testing followed by surgery, chemotherapy, immunotherapy, targeted therapy or radiotherapy.
Brain and central nervous system tumors may require neurosurgery, pathology, molecular classification, radiation oncology and medical oncology evaluation.
Hematological cancers are evaluated through blood tests, bone marrow examination, flow cytometry, molecular studies and transplantation assessment when indicated.
Treatment may include liver surgery, ablation, embolization, radioembolization, systemic therapy or transplantation assessment depending on diagnosis and liver function.
Pancreatic tumors may require dedicated CT or MRI, endoscopic ultrasound, biopsy, systemic treatment and complex surgery such as the Whipple procedure.
Evaluation includes colonoscopy, biopsy, CT, pelvic MRI and multidisciplinary planning for surgery, chemotherapy and radiotherapy.
Prostate cancer assessment may involve PSA, multiparametric MRI, PSMA PET/CT, biopsy review, surgery, radiotherapy, hormonal therapy and radionuclide treatment.
Thyroid cancer care may include ultrasound, biopsy, surgery, lymph node evaluation, radioactive iodine treatment and long-term hormonal monitoring.
Ovarian, uterine, cervical and other gynecological cancers are evaluated by gynecologic oncology, pathology, medical oncology and radiation oncology teams.
Sarcomas require planned imaging and biopsy before surgery. Treatment may include chemotherapy, radiotherapy, limb-preserving surgery and reconstructive procedures.
Children with leukemia, lymphoma, brain tumors, sarcoma and other cancers may receive multidisciplinary pediatric oncology and transplantation evaluation.
Accurate diagnosis and staging are essential for selecting the most appropriate treatment and monitoring response.
High-resolution imaging helps define tumor location, size, relationship to nearby structures and possible spread.
PET/CT may support staging, treatment-response assessment and evaluation of recurrence in selected cancers.
Tissue diagnosis confirms tumor type, grade and relevant biological characteristics before definitive treatment.
Next-generation sequencing and biomarker testing may identify actionable alterations for targeted therapy or immunotherapy.
Blood tests help evaluate organ function, treatment suitability and selected tumor markers.
Endoscopy, bronchoscopy and image-guided biopsy may be required to obtain tissue or evaluate internal organs.
Systemic therapies are selected according to cancer type, stage, pathology, biomarkers, previous treatments and the patient's general condition.
Chemotherapy may be used before surgery, after surgery or for advanced disease according to established treatment protocols.
Immunotherapy supports the immune system in recognizing and attacking selected cancers when clinical and biomarker criteria are met.
Targeted medicines act on specific molecular pathways or tumor alterations identified through pathology and genetic testing.
Hormonal treatment may be used for selected breast, prostate and other hormone-sensitive cancers.
Supportive treatment may address pain, nausea, infection risk, anemia, nutrition and treatment-related side effects.
Clinical assessment, laboratory tests and imaging are used to evaluate treatment effectiveness and adjust the plan when needed.
Cancer surgery may be performed for diagnosis, staging, curative removal, symptom relief or reduction of tumor burden.
The objective is to remove the tumor with appropriate surgical margins and regional lymph nodes when indicated.
Laparoscopic and robotic techniques may be considered for selected thoracic, abdominal, colorectal, urological and gynecological tumors.
Selected patients with peritoneal disease may be evaluated for removal of visible tumor deposits followed by heated intraperitoneal chemotherapy.
Plastic, vascular, orthopedic or other reconstructive teams may support complex cancer operations when tissue or organ reconstruction is required.
Surgery may relieve obstruction, bleeding, infection, pain or pressure when complete tumor removal is not possible.
Complex procedures may involve multiple surgical specialties and coordinated intensive care and postoperative support.
Radiation therapy uses carefully planned high-energy radiation to treat tumors while limiting exposure to surrounding healthy structures whenever possible.
Treatment may be delivered before surgery, after surgery, together with chemotherapy or for symptom control depending on the diagnosis and stage.
Explore Radiation OncologySelected cancers may be evaluated for targeted radionuclide therapies after diagnostic imaging, pathology and previous treatments are reviewed.
Selected patients with advanced prostate cancer and sufficient PSMA expression may be evaluated for Lu-177 PSMA treatment.
Alpha-particle therapy may be considered for selected advanced prostate cancer cases after specialist nuclear medicine evaluation.
Lutetium-177 DOTATATE may be used in selected receptor-positive neuroendocrine tumors.
Y-90 radioembolization delivers targeted radiation through the liver arteries for selected primary or metastatic liver tumors.
Radium-223 may be considered for selected prostate cancer patients with symptomatic bone-dominant metastatic disease.
Diagnostic nuclear imaging helps determine whether a tumor expresses the molecular target required for radionuclide treatment.
Stem cell transplantation may be considered for selected leukemia, lymphoma, myeloma, bone marrow failure syndromes and other hematological diseases.
Evaluation may include bone marrow examination, HLA testing, donor assessment, infection screening, organ-function tests and review of previous treatments.
Explore TransplantationFrom medical record review to treatment and follow-up, each stage is coordinated according to the patient's clinical needs.
Patients with a new cancer diagnosis, suspected cancer, recurrent disease, metastatic cancer or uncertainty about the current treatment plan may request specialist review.
Patients may also apply for a second opinion, tumor board review, advanced imaging, molecular testing, surgery, radiotherapy, nuclear medicine treatment or transplantation assessment.
Final recommendations depend on pathology, cancer stage, previous treatments, organ function and overall clinical condition.
Submit Medical ReportsPlease submit the available records to support a complete oncology evaluation and personalized treatment recommendation.
Current diagnosis, symptoms, general health, chronic illnesses, medication and previous cancer treatment.
Biopsy or surgical pathology results, immunohistochemistry, molecular tests and pathology slide information.
CT, MRI, PET/CT, ultrasound, mammography and other relevant radiology reports and original DICOM files.
Blood count, liver and kidney function, coagulation tests, tumor markers and other available results.
Chemotherapy protocols, radiotherapy summaries, operation notes, discharge reports and treatment-response information.
A clear passport copy supports patient registration, invitation documents and travel coordination when required.
Cancer treatment is individualized. Not every patient is suitable for surgery, immunotherapy, targeted therapy, radiotherapy, radionuclide therapy or transplantation.
The final treatment plan is determined only after specialist review of pathology, imaging, disease stage, previous treatments and the patient's current clinical condition.
Send your medical reports, pathology and imaging files to receive a multidisciplinary oncology evaluation and personalized treatment plan.